The fibrogenic role of TGF-β, IL-13/IL-4, and Egr-1 in patients with SSc has been assessed by performing genome-wide gene expression studies on lesional and non-lesional skin biopsies from patients with dcSSc, lcSSc, morphea, and healthy controls. The gene discussed is IL13; the disease is systemic sclerosis.